Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840444 · ClinicalTrials.gov registry record
Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep
A clinical trial of Insomnia and Adolescent, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06840444: Recruiting study of Insomnia and Adolescent, sponsored by University of Kansas Medical Center.
NCT06840444 is a study of Insomnia and Adolescent that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 40 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06840444, a study of Insomnia and Adolescent, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to form a Teen Advisory Board (TAB), who will partner with our study team to co-design a beta-test a new prototype of the Firefly program, a mobile-native insomnia cognitive behavioral therapy intervention for teens. This new prototype will have addressed issues that adolescents who had used the first version of the program deemed to be barriers to engaging with the treatment.
Conditions Studied
Interventions
- BEHAVIORAL Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens
Study Locations (1)
Kansas
- Kansas University Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2025-12 |
What NCT06840444 shows while recruiting
NCT06840444 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens is the first listed.
NCT06840444 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT06840444 about?
NCT06840444 is a clinical study titled "Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep". The goal of this study is to form a Teen Advisory Board (TAB), who will partner with our study team to co-design a beta-test a new prototype of the Firefly program, a mobile-native insomnia cognitive behavioral therapy intervention for teens. This new prototype will have addressed issues that adoles...
What is the current status of trial NCT06840444?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-04-01. Estimated completion is 2025-12.
What conditions does trial NCT06840444 study?
This clinical trial studies the following conditions: Insomnia, Adolescent, Digital Health.
What interventions are being tested in trial NCT06840444?
The interventions under investigation include: Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens (BEHAVIORAL).
Who is sponsoring clinical trial NCT06840444?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06840444 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06840444's enrollment target sits among peer trials
40 115th of 151 higher than 34 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®
RECRUITING
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
-
Pimavanserin for Insomnia in Veterans With PTSD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI